Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Mai 2018 16:01 ET | Quelle: resTORbio, Inc.

resTORbio Reports First Quarter 2018 Financial Results

Last patient dosed in Phase 2b trial; topline data now expected in third quarter of 2018 BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical...
09. Mai 2018 16:05 ET | Quelle: resTORbio, Inc.

resTORbio to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
09. Mai 2018 08:30 ET | Quelle: resTORbio, Inc.

resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly

BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
01. Mai 2018 16:05 ET | Quelle: resTORbio, Inc.

resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference

BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
29. März 2018 16:05 ET | Quelle: resTORbio, Inc.

resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results

BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and...
19. März 2018 08:00 ET | Quelle: resTORbio, Inc.

resTORbio Announces Formation of Clinical Advisory Board

Esteemed Experts Engaged as Company Advances Clinical Development Program Phase 2b Data for Lead Program Expected in the Second Half of 2018 BOSTON, March 19, 2018 (GLOBE NEWSWIRE) -- resTORbio,...
20. Februar 2018 08:00 ET | Quelle: resTORbio, Inc.

resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference

BOSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the...
30. Januar 2018 16:01 ET | Quelle: resTORbio, Inc.

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the...
25. Januar 2018 19:55 ET | Quelle: resTORbio, Inc.

resTORbio Announces Pricing of Initial Public Offering

BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of...